JACC. Cardiovascular interventions最新文献

{"title":"Simultaneous Multiple Distinct Plaque Erosions Within a Single Coronary Artery","authors":"David del Val MD, PhD , Alexander Marschall MD, PhD , Teresa Bastante MD , Fernando Rivero MD, PhD , Javier Cuesta MD, PhD , Fernando Alfonso MD, PhD","doi":"10.1016/j.jcin.2024.09.009","DOIUrl":"10.1016/j.jcin.2024.09.009","url":null,"abstract":"","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"17 20","pages":"Pages 2441-2442"},"PeriodicalIF":11.7,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142535637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Percutaneous Coronary Interventions Using Calcium Modification and Intravascular Imaging","authors":"Fabian J. Brunner MD , Peter Moritz Becher MD , Marko Remmel MD, Jessica Weimann MSc, Benjamin Bay MD, Christoph Waldeyer MD, Benedikt Schrage MD, PhD, Stefan Blankenberg MD, Peter Clemmensen MD, Moritz Seiffert MD","doi":"10.1016/j.jcin.2024.06.030","DOIUrl":"10.1016/j.jcin.2024.06.030","url":null,"abstract":"","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"17 20","pages":"Pages 2450-2452"},"PeriodicalIF":11.7,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142535639","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Microsnare Technique for Transcatheter Heart Valve Recrossing After Inadvertent Wire Withdrawal From Left Ventricle","authors":"Polydoros N. Kampaktsis MD, Craig Basman MD, Sung-Han Yoon MD, Perry Wengrofsky MD, Vladimir Jelnin MD, Yuriy Dudiy MD, Ryan Kaple MD","doi":"10.1016/j.jcin.2024.08.043","DOIUrl":"10.1016/j.jcin.2024.08.043","url":null,"abstract":"","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"17 20","pages":"Pages 2448-2449"},"PeriodicalIF":11.7,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142535638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A Novel Technique for the Common Femoral Artery and its Bifurcation","authors":"Maxime Dubosq-Lebaz MD, MSc , Bahaa Nasr MD, PhD , Yann Gouëffic MD, PhD","doi":"10.1016/j.jcin.2024.07.035","DOIUrl":"10.1016/j.jcin.2024.07.035","url":null,"abstract":"","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"17 20","pages":"Pages 2446-2447"},"PeriodicalIF":11.7,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142465739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Contemporary Practice Patterns and Outcomes of Endovascular Revascularization of Acute Limb Ischemia","authors":"Matthew S. Herzig MD ,&nbsp;Kevin F. Kennedy MS ,&nbsp;Beau M. Hawkins MD ,&nbsp;Eric A. Secemsky MD, MSc","doi":"10.1016/j.jcin.2024.09.010","DOIUrl":"10.1016/j.jcin.2024.09.010","url":null,"abstract":"<div><h3>Background</h3><div>Acute limb ischemia is a vascular emergency associated with high rates of limb loss and mortality. As the use of endovascular techniques increases, estimation of rates and predictors of adverse outcomes remains needed.</div></div><div><h3>Objectives</h3><div>This study sought to assess contemporary outcomes and predictors of adverse events following endovascular treatment of acute limb ischemia in a nationwide, multicenter registry.</div></div><div><h3>Methods</h3><div>Patients who had peripheral vascular intervention performed for the indication of acute limb ischemia in National Cardiovascular Data Registry Peripheral Vascular Intervention Registry between 2014 and 2020 were included. The primary outcome was a composite of all-cause mortality and major amputation during index hospitalization. Multivariable logistic regression was employed to identify predictors of the composite outcome.</div></div><div><h3>Results</h3><div>There were 3,541 endovascular procedures performed during the study period. Of these, 132 (3.7%) resulted in death, and 77 (2.2%) resulted in amputation during hospitalization. Thrombolysis catheters were used in 27.7% (n = 981) and thrombectomy catheters in 3.9% (n = 138). Independent predictors of death or amputation included severe lung disease (OR: 1.72; 95% CI: 1.17-2.52), Rutherford Class IIb (OR: 2.44; 95% CI: 1.62-3.65), and end-stage renal disease (OR: 3.94; 95% CI: 0.73-0.85), and preprocedure hemoglobin (OR: 0.78; 95% CI: 0.73- 0.85). Complications included bleeding within 72 hours of intervention (6.7%) and thrombosis (2.8%).</div></div><div><h3>Conclusions</h3><div>Patients with pre-existing medical comorbidities and those with diminished limb viability were more likely to suffer adverse outcomes. Adverse event rates remain high for patients affected by acute limb ischemia despite its declining incidence.</div></div>","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"17 20","pages":"Pages 2379-2390"},"PeriodicalIF":11.7,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142535115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reclassification of CTO Crossing Strategies in the ERCTO Registry According to the CTO-ARC Consensus Recommendations","authors":"Giuseppe Vadalà MD ,&nbsp;Kambis Mashayekhi MD, PhD ,&nbsp;Marouane Boukhris MD ,&nbsp;Michael Behnes MD, PhD ,&nbsp;Stylianos Pyxaras MD, PhD ,&nbsp;Evald Høj Christiansen MD, PhD ,&nbsp;Juan Luis Gutiérrez-Chico MD, PhD ,&nbsp;Laura Maniscalco PhD ,&nbsp;Sinisa Stojkovic MD, PhD ,&nbsp;Nenad Z. Bozinovic MD ,&nbsp;Nicolaus Boudou MD ,&nbsp;Roberto Garbo MD ,&nbsp;Gerald S. Werner MD, PhD ,&nbsp;Alexander Avran MD ,&nbsp;Gabriele L. Gasparini MD ,&nbsp;Eugenio La Scala MD ,&nbsp;Andrew Ladwiniec MD ,&nbsp;George Sianos MD ,&nbsp;Omer Goktekin MD, PhD ,&nbsp;Sevket Gorgulu MD ,&nbsp;Alfredo R. Galassi MD","doi":"10.1016/j.jcin.2024.09.002","DOIUrl":"10.1016/j.jcin.2024.09.002","url":null,"abstract":"<div><h3>Background</h3><div>The CTO-ARC (Chronic Total Occlusion Academic Research Consortium) recognized that a nonstandardized definition of chronic total occlusion (CTO) percutaneous coronary intervention approaches can bias the complications’ attribution to each crossing strategy.</div></div><div><h3>Objectives</h3><div>The study sought to describe the numbers, efficacy, and safety of each final CTO crossing strategy according to CTO-ARC recommendations.</div></div><div><h3>Methods</h3><div>In this cross-sectional study, data were retrieved from the European Registry of Chronic Total Occlusions between 2021 and 2022.</div></div><div><h3>Results</h3><div>Out of 8,673 patients, antegrade and retrograde approach were performed in 79.2% and 20.8% of cases, respectively. The antegrade approach included antegrade wiring and antegrade dissection and re-entry, both performed with or without retrograde contribution (antegrade wiring without retrograde contribution: n = 5,929 [68.4%]; antegrade wiring with retrograde contribution: n = 446 [5.1%]; antegrade dissection and re-entry without retrograde contribution: n = 353 [4.1%]; antegrade dissection and re-entry with retrograde contribution: n = 137 [1.6%]). The retrograde approach included retrograde wiring (n = 735 [8.4%]) and retrograde dissection and re-entry (n = 1,073 [12.4%]). Alternative antegrade crossing was associated with lower technical success (70% vs 86% vs 93.1%, respectively; <em>P</em> &lt; 0.001) and higher complication rates (4.6% vs 2.9% vs 1%, respectively; <em>P</em> &lt; 0.001) as compared with retrograde and true antegrade crossing. However, alternative antegrade crossing was applied mostly as a rescue strategy (96.1%).</div></div><div><h3>Conclusions</h3><div>The application of CTO-ARC definitions allowed the reclassification of 6.7% of procedures as alternative antegrade crossing with retrograde or antegrade contribution which showed higher MACCE and lower technical success rates, as compared with true antegrade and retrograde crossing.</div></div>","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"17 20","pages":"Pages 2425-2437"},"PeriodicalIF":11.7,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142535635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Reclassifying Bailout Strategies in CTO PCI","authors":"Emil Nielsen Holck MD, PhD ,&nbsp;Lorenzo Azzalini MD, PhD, MSc","doi":"10.1016/j.jcin.2024.09.051","DOIUrl":"10.1016/j.jcin.2024.09.051","url":null,"abstract":"","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":"17 20","pages":"Pages 2438-2440"},"PeriodicalIF":11.7,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142535636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Coronary Intravascular Lithotripsy for In-Stent Restenosis: The ACC NCDR CathPCI Registry.","authors":"Dean J Kereiakes, Richard A Shlofmitz, Andrew J Klein, Robert F Riley, Matthew J Price, Howard C Herrmann, William Bachinsky, Ron Waksman, Nick E J West, Gregg W Stone","doi":"10.1016/j.jcin.2024.09.028","DOIUrl":"https://doi.org/10.1016/j.jcin.2024.09.028","url":null,"abstract":"","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":" ","pages":""},"PeriodicalIF":11.7,"publicationDate":"2024-10-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142682007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Meta-Analysis of Dedicated vs Off-Label Transcatheter Devices for Native Aortic Regurgitation.","authors":"Sahar Samimi, Taha Hatab, Chloe Kharsa, Safi U Khan, Rody G Bou Chaaya, Fatima Qamar, Joe Aoun, Syed Zaid, Nadeen Faza, Marvin D Atkins, Stephen H Little, William A Zoghbi, Michael J Reardon, Neal S Kleiman, Sachin S Goel","doi":"10.1016/j.jcin.2024.08.042","DOIUrl":"https://doi.org/10.1016/j.jcin.2024.08.042","url":null,"abstract":"<p><strong>Background: </strong>Transcatheter aortic valve replacement (TAVR) for high surgical risk patients with severe native aortic regurgitation (AR) presents unique challenges. Dedicated devices such as the JenaValve (JenaValve Technology) and J-Valve (JC Medical Inc) show promising results in addressing these challenges.</p><p><strong>Objectives: </strong>This study compares the safety and efficacy of dedicated vs off-label devices among high surgical risk patients with pure native AR.</p><p><strong>Methods: </strong>We systematically searched PubMed, EMBASE, and Cochrane Central Register of Controlled Trials through July 11, 2024, for studies on TAVR among patients with pure severe native AR. The primary endpoint was 30-day all-cause mortality. Secondary endpoints were device success, residual AR ≥ moderate, valve embolization/migration, pacemaker implantation, reintervention, and all-cause mortality at 1 year. Summary estimates were constructed using a random effects model.</p><p><strong>Results: </strong>A total of 34 studies encompassing 2,162 patients (mean age 75.4 ± 0.2, 42.8% women) were included in the meta-analysis. Patients undergoing TAVR with dedicated devices had a lower all-cause 30-day mortality rate (3% vs 9%; P < 0.01) and higher device success (93% vs 82%; P < 0.01) compared with off-label devices. The risk of AR ≥ moderate (2% vs 5%; P = 0.03), valve embolization/migration (2% vs 8%; P < 0.01), pacemaker implantation (11% vs 20%; P < 0.01), and reintervention (4% vs 10%; P < 0.01) at 30 days and all-cause mortality at 1 year (6% vs 24%; P < 0.01) were lower in the dedicated device group.</p><p><strong>Conclusions: </strong>Dedicated TAVR devices for native AR show superior device success and reduced mortality, residual AR, and reintervention rates compared with off-label devices. These findings support the use of dedicated devices as a safer alternative for high-risk patients.</p>","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":" ","pages":""},"PeriodicalIF":11.7,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142682010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Coronary Sinus Reducer as a Game-Changer for the Treatment of Coronary Microvascular Dysfunction.","authors":"Tim P van de Hoef","doi":"10.1016/j.jcin.2024.09.007","DOIUrl":"https://doi.org/10.1016/j.jcin.2024.09.007","url":null,"abstract":"","PeriodicalId":14688,"journal":{"name":"JACC. Cardiovascular interventions","volume":" ","pages":""},"PeriodicalIF":11.7,"publicationDate":"2024-10-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142620820","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}